Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

164.70
Delayed Data
As of Apr 25
 +1.56 / +0.96%
Today’s Change
133.64
Today|||52-Week Range
184.21
+12.65%
Year-to-Date
Trump's tax plan; Boeing in focus; Earnings deluge
5:03am / CNNMoney.com
Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong
Apr 25 / Zacks.com - Paid Partner Content
Martin Whitman Sells Comerica, Buys Amgen
Apr 25 / GuruFocus News - Paid Partner Content
Why Earnings Season Could Be Great for Amgen (AMGN)
Apr 25 / Zacks.com - Paid Partner Content
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
Apr 25 / Zacks.com - Paid Partner Content
Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More
Apr 25 / Zacks.com - Paid Partner Content
Novartis, Amgen Divvy Global Marketing of New Migraine Drug
Apr 25 / TheStreet.com - Paid Partner Content
Korea Investment CORP Buys Johnson & Johnson, Amgen, Philip Morris International, Sel...
Apr 25 / GuruFocus News - Paid Partner Content
Novartis Tops Q1 Earnings: Cosentyx, Entresto Boost Sales
Apr 25 / Zacks.com - Paid Partner Content
Celgene (CELG) to Post Q1 Earnings: What's in the Cards?
Apr 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close163.14
Today’s open163.52
Day’s range163.40 - 165.30
Volume3,529,408
Average volume (3 months)3,661,962
Market cap$120.1B
Dividend yield2.79%
Data as of 04/25/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+5.93%
Earnings growth (next 5 years)+6.44%
Revenue growth (last year)+6.31%
P/E ratio16.1
Price/Sales4.86
Price/Book4.03

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.87+1.31%
BIIBBiogen+10.03+3.62%
ILMNIllumina Inc+1.30+0.72%
BIVVBioverativ Inc-0.41-0.70%
Data as of 04/25/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.98
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs